Skip to main content

Table 2 Nondepolarising neuromuscular blockade management

From: Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study

 

Agent

n/total (%)

Total dose (mg)

Total dose (mg kg− 1)

Nondepolarising neuromuscular blockade

Rocuronium

176/240 (73%)

54.15 ± 29.06

0.61 ± 0.18

Vecuronium

56/240 (23.3%)

8.23 ± 6.52

0.08 ± 0.025

Atracurium

8/240 (3.3%)

41.87 ± 16.89

0.42 ± 0.067

  1. n Number of patients
  2. Data are presented as the mean ± standard deviation or numbers